Post by AstraZeneca Hematology Ambition

Hematology innovation is rapidly evolving. Nilsa S., VP, Head of Hematology, US Oncology, shares her reflections from this year’s American Society of Clinical Oncology (ASCO) Annual Meeting and European Hematology Association (EHA) Congress.    “As we look back on the dialogue from ASCO and EHA, we’re reenergized by the scientific advancements that are emerging in hematology and the potential to bring forward new possibilities in blood cancer care.”    Learn more about our dedication to innovative research: https://bit.ly/4nracRj     #AZHemeAmbition #ASCO26 #EHA2026